Alerts will be sent to your verified email
Verify Email
AMERISE
|
Amerise Biosciences
|
Global Securities
|
Asia Capital
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.9 % | -0.33 % | 4.51 % |
|
5yr average Equity Multiplier
|
1.27 | 1.62 | 1.17 |
|
5yr Average Asset Turnover Ratio
|
0.15 | 2.12 | 0.09 |
|
5yr Avg Net Profit Margin
|
1.22 % | -0.11 % | 41.57 % |
|
Price to Book
|
0.93 | n/a | 0.97 |
|
P/E
|
97.08 | n/a | 16.89 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 0.0 |
|
Inventory Days
|
0.0 | 0.0 | 0.0 |
|
Days Receivable
|
0.0 | 0.0 | 0.0 |
|
Days Payable
|
275.57 Days | 61.17 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
-475.34 | -1370.67 | 0.0 |
|
5yr Avg ROCE
|
-0.92 % | -0.21 % | 6.11 % |
|
5yr Avg Operating Profit Margin
|
-0.04 % | -8.71 % | 56.18 % |
|
5 yr average Debt to Equity
|
0.01 | 0.22 | 0.15 |
|
5yr CAGR Net Profit
|
0.0 | n/a | -2.76 % |
|
5yr Average Return on Assets
|
-1.74 % | -0.26 % | 3.89 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 9.14 % | 75.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -2.3 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Amerise Biosciences
|
Global Securities
|
Asia Capital
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|